Inhalation of [123I]α1-protease inhibitor: Toward a new therapeutic concept of α1-protease inhibitor deficiency?

Journal of Nuclear Medicine

Volumn 42, Issue 5, 2001, Pages 744-751

  Kropp, J ^a   Wencker, M ^a   Hotze, A ^a   Banik, N ^a   Hubner G E ^a   Wunderlich, G ^a   Ulbrich, E ^a   Konietzko, N ^a   Biersack, H J ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

1 protease inhibitor; 123I 1 Pi; Antitrypsin; Inhalation therapy; Prolastin

Indexed keywords

ALPHA 1 ANTITRYPSIN; IODINE 123; PHENOBARBITAL; RADIOACTIVE IODINE;

ADULT; AEROSOL; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG STABILITY; DRUG UPTAKE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL DISEASE; HUMAN; ISOTOPE LABELING; MALE; PARTICLE SIZE; PRIORITY JOURNAL; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IODINE RADIOISOTOPES; LUNG; MALE; MIDDLE AGED; PHENOBARBITAL;

EID: 0034744066     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)